About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Change of Registered Office and Principal Place of Business
January 20, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Newsletter – December 2016
Next Post
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
Related Posts
2016 Sep 12 Phosphagenics Updates Long Term Incentive Scheme
September 12, 2016
Phosphagenics’ PHN Trial Completes Enrolment and Dosing
December 17, 2015
Quarterly Activities Report and 4C
July 27, 2021
July 27, 2021